Efficacy and safety of immune checkpoint inhibitors in elderly patients with primary liver cancer: a retrospective, multicenter, real-world cohort study

Xiao, LS; Liao, YX; Wang, JR; Li, QM; Zhu, HB; Hong, C; Li, RN; He, JZ; Cui, H; Dong, HZ; Zeng, L; Liu, L

Cui, H; Zeng, L; Liu, L (通讯作者)，Southern Med Univ, Nanfang Hosp, Big Data Ctr, Guangzhou 510515, Peoples R China.;Cui, H; Zeng, L; Liu, L (通讯作者)，Southern Med Univ, Nanfang Hosp, Dept Infect Dis, Guangzhou 510515, Peoples R China.;Dong, HZ (通讯作者)，Jiangxi Canc Hosp, Affiliated Hosp 2, Jiangxi Clin Res Ctr Canc, Dept Med Oncol,Nanchang Med Coll, Nanchang 330029, Peoples R China.

CANCER IMMUNOLOGY IMMUNOTHERAPY, 2023; 72 (7): 2299

Abstract

BackgroundThere is still no specific real-world data regarding the clinical activity of immune checkpoint inhibitors in the elderly with liver cancer.......

Full Text Link


Links

期刊讨论 | 中国SCI论文 | 期刊主页 | 投稿经验 | 杂志官网 | 投稿链接 | 作者需知 | PMC链接 | Pubmed全文检索